NAFDAC GOES TOUGH ON THE SHARED EFFICACY OF BRANDED AND GENERIC MEDICINES 

The National Agency for Food and Drug Administration and Control (NAFDAC) has unveiled a new regulatory framework mandating bioequivalence (BE) studies for all generic medicines in Nigeria. The NAFDAC Director General, Prof. Mojisola Christianah Adeyeye, said the new requirement ensures that generic drugs provide the same therapeutic effect as their branded counterparts. “Bioequivalence is not…

Read More